Cargando…
Targeted therapy for mucinous ovarian carcinoma: evidence from clinical trials
Mucinous ovarian carcinoma is a rare subtype of epithelial ovarian cancer. Despite being a chemoresistant tumour type, surgical resection and chemotherapy are still the current standard for management. This narrative review aims to explore the current evidence for targeted therapies in mucinous ovar...
Autores principales: | Nugawela, Devindee, Gorringe, Kylie L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9811085/ https://www.ncbi.nlm.nih.gov/pubmed/36603894 http://dx.doi.org/10.1136/ijgc-2022-003658 |
Ejemplares similares
-
The Protein Landscape of Mucinous Ovarian Cancer: Towards a Theranostic
por: Youssef, Arkan, et al.
Publicado: (2021) -
Mutational landscape of mucinous ovarian carcinoma and its neoplastic precursors
por: Ryland, Georgina L., et al.
Publicado: (2015) -
Erratum to: Mutational landscape of mucinous ovarian carcinoma and its neoplastic precursors
por: Ryland, Georgina L., et al.
Publicado: (2017) -
Therapeutic options for mucinous ovarian carcinoma☆
por: Gorringe, Kylie L., et al.
Publicado: (2020) -
Recent Insights into Mucinous Ovarian Carcinoma
por: Ricci, Francesca, et al.
Publicado: (2018)